BN Business News
Add your company to Business Communicator →

Market regulation · 03/07/1995Updated: 10/18/2026 · 1 min read

Arizona Institute of Reproductive Medicine, Ltd. to Settle Allegations of Misrepresentation in Fertility Services

Summary

The Arizona Institute of Reproductive Medicine, Ltd. has agreed to a consent agreement with the Commission, which would prohibit the company and its president from making false claims about the success rate of their in vitro fertilization program and other infertility treatment services, and require them to have reliable scientific evidence to support such claims.

Original source language: Federal Register — Federal Trade CommissionOpen original release →

Explore insights

Business insights →